Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
According to Biogen's latest financial reports the company's current earnings are $9.81 Billion USD. In 2024 the company made an earning of $1.90 Billion USD, an increase over its 2023 earnings that were of $1.29 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $1.75 B | -8.06% |
2024 | $1.90 B | 46.98% |
2023 | $1.29 B | -63.9% |
2022 | $3.59 B | 105.81% |
2021 | $1.74 B | -65.43% |
2020 | $5.04 B | -29.17% |
2019 | $7.12 B | 20.79% |
2018 | $5.89 B | 15.03% |
2017 | $5.12 B | 3.97% |
2016 | $4.93 B | 3.48% |
2015 | $4.76 B | 20.79% |
2014 | $3.94 B | 59.1% |
2013 | $2.48 B | 33.72% |
2012 | $1.85 B | 8.41% |
2011 | $1.71 B | 39.13% |
2010 | $1.22 B | -7.71% |
2009 | $1.33 B | 15.47% |
2008 | $1.15 B | 26.74% |
2007 | $0.91 B | 85.02% |
2006 | $0.49 B | 92.11% |
2005 | $0.25 B | 299.73% |
2004 | $64.09 M | -106.82% |
2003 | -$0.94 Billion | -439.73% |
2002 | $0.27 B | -28.99% |
2001 | $0.38 B | -20.04% |
2000 | $0.48 B | 48% |
1999 | $0.32 B | 56.65% |
1998 | $0.21 B | 41.03% |
1997 | $0.14 B | 264.86% |
1996 | $40.82 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $6.65 B | 279.48% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $6.82 B | 289.47% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $3.62 B | 106.69% | ๐บ๐ธ USA |
![]() Pfizer PFE | $10.34 B | 490.10% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $27.40 B | 1,464.03% | ๐บ๐ธ USA |
![]() Acorda Therapeutics
ACOR | -$0.28 Billion | -115.51% | ๐บ๐ธ USA |
![]() Sanofi SNY | $8.78 B | 401.05% | ๐ซ๐ท France |
![]() Bio-Rad Laboratories BIO | -$2.76 Billion | -256.94% | ๐บ๐ธ USA |
![]() Illumina ILMN | -$0.79 Billion | -144.57% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $0.17 B | -89.77% | ๐ณ๐ฑ Netherlands |